Searched for
WOCKHARDT GROUP FOUNDER
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...- Wockhardt, Jemincare partner for novel respiratory antibiotic NafithromycinOn the development, Wockhardt Group Founder Chairman Habil Khorakiwala said Wockhardt has been at the forefront in the fight against Anti-M...
- Covid-19: Wockhardt inks pact with RDIF to produce, supply Sputnik vaccineThe Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF...
- Wockhardt's COVID-19 vaccines supply deal with UK Govt extended for 6 monthsOn the development, UK International Trade Secretary Liz Truss said, "It brings important investment to the local area, bringing jobs and s...
- Wockhardt gets QIDP designation from USFDA for its combination antibioticThe QIDP status is granted to drugs that are effective against a set of multi-drug resistant pathogens identified by the Centre for Disease...
- Wockhardt to sell 62 products, Baddi unit to Dr Reddy’s for Rs 1,850 croreIn a regulatory filing on Wednesday, Wockharrdt said Dr Reddy’s Labs will acquire 62 products and its unit in Baddi, Himachal Pradesh in a ...
- Wockhardt gets DGCI approval for 2 new antibiotics"DCGI (Drug Controller General of India) has approved Wockhardt's two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial s...
- Wockhardt gets USFDA nod for generic cancer drugWockhardt's Imatinib Mesylate tablets are a generic version of Gleevec, marketed in USA and other countries by Novartis.
- Shekhar Gupta feted with V Krishnamurthy awardSenior journalist Shekhar Gupta was presented the annual 'V Krishnamurthy award for excellence' by Tamil Nadu Governor K Rosaiah.
- Wockhardt gets USFDA nod to market anti-epilepsy tabletsThe tablets will be manufactured at the company's facility at Aurangabad.
- Wockhardt gets USFDA approval for anti-ulcer drugDrug firm Wockhardt today said it has received approval from American health regulator to market Lansoprazole, a drug used in treatment of ...
- Wockhardt gets USFDA nod for anti-depressant tabletsWockhardt said it has received final approval from USFDA for marketing tablets used for treating depression.
- Wockhardt gets tentative USFDA nod for anti-psychotic drugPharmaceutical firm Wockhardt today said it has received tentative approval from US health regulator for its generic version of anti-psycho...
- Wockhardt Hospitals aims at business from tier-II townsAs the group clambers out of a debt trap, Habib Khorakiwala’s daughter Zahabiya plans strategy to get hospital biz back on track.
- Wockhardt gets final USFDA approval for anti-hypertension drugWockhardt today said it has received final approval from the US health regulator to market generic Felodipine tablets used for treating hyp...
- Wockhardt gets USFDA nod for tablets to check heart attackDrug firm Wockhardt said it has received USFDA approval to market clopidogrel bisulfate tablets used for reducing risk of heart attack.
- Wockhardt gets USFDA nod for generic UroxatralWockhardt today said it has received approval from the American health regulator USFDA to market Alfuzosin hydrochloride tablets.
- Sun flouted foreign currency norms, Wockhardt tells RBIWockhardt has drawn RBIs attention to possible violation of foreign currency laws by Sun Pharma.
- Fortis to buy key Wockhardt hospitals for Rs 1k crFortis Healthcare is all set to buy some of Wockhardt’s key hospitals in a transaction that will see it edge closer to industry leader Apol...
- Wockhardt tie-up with US coWockhardt Hospitals, a leading healthcare provider group, on Monday announced a strategic tie up with US based IndUShealth Inc., a global h...
Load More
